MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 208 filers reported holding MIRATI THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.22 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $406,786 | -43.5% | 10,941 | -31.2% | 0.00% | -50.0% |
| Q4 2022 | $720,520 | -100.0% | 15,902 | -24.0% | 0.01% | -50.0% |
| Q3 2022 | $1,461,053,000 | +79004.1% | 20,920 | -24.0% | 0.02% | -11.1% |
| Q2 2022 | $1,847,000 | +67.9% | 27,517 | +105.7% | 0.02% | +125.0% |
| Q1 2022 | $1,100,000 | -70.8% | 13,375 | -48.0% | 0.01% | -42.9% |
| Q4 2021 | $3,772,000 | – | 25,714 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 1,000,000 | $31,470,000 | 8.67% |
| Baker Brothers Advisors | 2,805,074 | $88,276,000 | 0.77% |
| Broadfin Capital, LLC | 359,661 | $11,319,000 | 0.61% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 397,660 | $12,514,000 | 0.42% |
| Boulegeris Investments, Inc. | 17,415 | $548,000 | 0.39% |
| SPHERA FUNDS MANAGEMENT LTD. | 95,000 | $2,990,000 | 0.29% |
| Rhenman & Partners Asset Management AB | 50,000 | $1,574,000 | 0.19% |
| Integre Asset Management, LLC | 23,996 | $755,000 | 0.16% |
| Orbimed Advisors | 680,500 | $21,415,000 | 0.16% |
| EAM Investors, LLC | 38,754 | $1,220,000 | 0.14% |